Global Cardiac Biomarkers Testing Market Report 2024

Cardiac Biomarkers Testing Global Market Report 2024 – By Biomarkers Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types), By Application (Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications), By End-User (Hospitals, Specialty Clinics) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Cardiac Biomarkers Testing Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cardiac Biomarkers Testing Market Definition And Segments

Cardiac biomarkers testing refers to the tests to evaluate the quantities of cardiac biomarkers in blood. It is used to diagnose, assess, and keep track of people who may have acute coronary syndrome (ACS).

The types of biomarkers in cardiac biomarkers testing are creatine kinase (CK-MB), troponins, myoglobin, natriuretic peptides (BNP and NT-proBNP), ischemia-modified albumin (IMA) and others. Creatine kinase (CK-MB) refers to a blood test that looks for a particular enzyme. The various applications involved are congestive heart failure, acute coronary syndrome, myocardial infarction, atherosclerosis and others, with hospitals and specialty clinic end-users.

The cardiac biomarkers testing market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

The cardiac biomarkers testing market size has grown rapidly in recent years. It will grow from $12.15 billion in 2023 to $13.63 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, aging population, awareness and education initiatives, government initiatives and healthcare policies, increasing healthcare expenditure.

The cardiac biomarkers testing market size is expected to see rapid growth in the next few years. It will grow to $21.31 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to personalized medicine, rising global burden of cardiovascular diseases, integration of artificial intelligence (ai) in diagnostics, expansion of point-of-care testing, increasing emphasis on early disease detection. Major trends in the forecast period include technological advancements, advancements in ai-assisted diagnostics, point-of-care testing (POCT) growth, multiplexing capabilities, biomarker discovery and validation.

Rising Prevalence Of Cardiovascular Diseases Fuels Growth In The Cardiac Biomarkers Testing Market

The increasing prevalence of cardiovascular diseases is expected to boost the growth of the cardiac biomarkers testing market going forward. Cardiovascular disease refers to a type of condition that affects the heart or blood vessels. Cardiac biomarker tests assist in determining the levels of biomarkers to immediately determine the severity of a heart attack and its magnitude. Hence, an increase in the prevalence of cardiovascular diseases will lead to an increase in the demand for cardiac biomarker testing solutions. For instance, in August 2022, according to the American College of Cardiology, a US-based professional medical organization, the expected rates of cardiovascular risk factors and disease will considerably rise in the United States by the year 2060. Therefore, an increase in the prevalence of cardiovascular diseases is driving the growth of the cardiac biomarkers testing market.

Revolutionizing Cardiovascular Care Through The Intersection Of Cardiac Biomarkers Testing And Personalized Medicine

The growing demand for personalized medical solutions is expected to propel the growth of the cardiac biomarkers testing market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and drug therapies to the individual patient. The integration of cardiac biomarkers testing into personalized medicine enhances the precision of cardiovascular care, leading to more effective prevention, early detection, and treatment strategies tailored to individual patient needs. For instance, in October 2022, according to reports published by STAT, a US-based health-oriented news company, there were more than 75,000 genetic testing products and 300 personalized medicines. Therefore, the growing demand for personalized medicine is driving the growth of the cardiac biomarkers testing market.

Major companies operating in the cardiac biomarkers testing market report are Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech PLC, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam PLC, Bio-Techne Corporation .

Breakthrough In Cardiac Biomarker Testing With Atellica VTLi Patient-Side Immunoassay Analyzer

Product innovations are a key trend gaining popularity in the cardiac biomarker testing market. Major companies operating in the cardiac biomarker testing market are focusing on developing innovative products to sustain their market position. For instance, in October 2021, Siemens Healthcare GmbH, a Germany-based medical technology company, launched the Atellica VTLi Patient-Side Immunoassay Analyzer. The unique feature of the Atellica VTLi Patient-Side Immunoassay Analyzer is its high-sensitivity troponin I test from a fingerstick sample. Clinicians and healthcare professionals can enhance outcomes for patients by using it to help diagnose a heart attack fast and reliably in eight minutes.

Elevating Cardiovascular Care With Innovative Troponin I And Nt-Probnp Cardiac Biomarkers

Major companies operating in the cardiac biomarker testing market are focusing on innovative products such as cardiac biomarkers to drive revenues in their market. Cardiac biomarkers, also known as cardiac enzymes, are substances that are released into the bloodstream when the heart muscle is damaged. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. a China-based company that specializes in the development, manufacture, and distribution of medical equipment and solutions launched troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has surpassed the minimal requirements for hs-cTn in terms of sensitivity, accuracy, and reliability in identifying myocardial damage. These new products are intended to support improved treatment for cardiovascular illnesses by giving dependable solutions that improve patient outcomes both within and beyond the context of cardiovascular illnesses.

Mindray Expands Global Footprint And Innovates In Ivd With Strategic Acquisition Of HyTest

In September 2021, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical instrumentation manufacturer, acquired HyTest Invest Oy and its subsidiaries (“HyTest”) for an undisclosed amount. with this acquisition, Mindray will have excellent R&D and innovation capabilities for raw materials and will help HyTest maintain its status as a world leader in the upstream IVD raw material industry by supporting its continued investment in R&D as well as strengthening and improving its core competitive edge. HyTest Ltd is a US-based provider of antibodies and antigens focused on the IVD market including cardiac indicators, inflammation, tumor markers and others.

North America was the largest region in the cardiac biomarkers testing market in 2023. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cardiac biomarkers testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac biomarkers testing market includes revenues earned by entities by providing ischemia-modified albumin (IMA), peptides, and C-reactive protein (CRP) biomarkers testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cardiac biomarkers testing market research report is one of a series of new reports from The Business Research Company that provides cardiac biomarkers testing market statistics, including cardiac biomarkers testing industry global market size, regional shares, competitors with cardiac biomarkers testing market share, detailed cardiac biomarkers testing market segments, market trends, and opportunities, and any further data you may need to thrive in the cardiac biomarkers testing industry. This cardiac biomarkers testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cardiac Biomarkers Testing Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $13.63 billion
Revenue Forecast In 2033 $21.31 billion
Growth Rate CAGR of 11.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Abbott Laboratories; Bio-Rad Laboratories Inc.; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; Thermo Fisher Scientific Inc.; Biomérieux SA; Becton Dickinson and Company; Randox Laboratories Ltd.; Enzo Biochem Inc.; Creative Diagnostics Inc.; Merck Co. & KGaA; Beckman Coulter Inc.; QIAGEN N.V.; PerkinElmer Inc.; Tosoh Corporation; Eurolyser Diagnostica GmbH; Cortez Diagnostics Inc.; DIALAB GmbH; CardioGenics Holdings Inc.; Lepu Medical Technology (Beijing) Co. Ltd.; Biosynex SA; Charles River Laboratories; Quidel Corporation; Life Diagnostics; Trinity Biotech plc; Guangzhou Wondfo Biotech Co. Ltd.; Nova Biomedical Corp.; Ortho Clinical Diagnostics Inc.; Sekisui Diagnostics Inc.; Abcam plc; Bio-Techne Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cardiac Biomarkers Testing Market Characteristics

    3. Cardiac Biomarkers Testing Market Trends And Strategies

    4. Cardiac Biomarkers Testing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Cardiac Biomarkers Testing Market Size and Growth

    5.1. Global Cardiac Biomarkers Testing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cardiac Biomarkers Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cardiac Biomarkers Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cardiac Biomarkers Testing Market Segmentation

    6.1. Global Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Creatine Kinase (CK-MB)

    Troponins

    Myoglobin

    Natriuretic Peptides (BNP and NT-proBNP)

    Ischemia Modified albumin (IMA)

    Other Biomarkers Types

    6.2. Global Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Congestive Heart Failure

    Acute Coronary Syndrome

    Myocardial Infarction

    Atherosclerosis

    Other Applications

    6.3. Global Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Specialty Clinics

    7. Cardiac Biomarkers Testing Market Regional And Country Analysis

    7.1. Global Cardiac Biomarkers Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cardiac Biomarkers Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cardiac Biomarkers Testing Market  

    8.1. Asia-Pacific Cardiac Biomarkers Testing Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cardiac Biomarkers Testing Market  

    9.1. China Cardiac Biomarkers Testing Market Overview  

    9.2. China Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cardiac Biomarkers Testing Market  

    10.1. India Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cardiac Biomarkers Testing Market  

    11.1. Japan Cardiac Biomarkers Testing Market Overview  

    11.2. Japan Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cardiac Biomarkers Testing Market  

    12.1. Australia Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cardiac Biomarkers Testing Market  

    13.1. Indonesia Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cardiac Biomarkers Testing Market  

    14.1. South Korea Cardiac Biomarkers Testing Market Overview  

    14.2. South Korea Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cardiac Biomarkers Testing Market  

    15.1. Western Europe Cardiac Biomarkers Testing Market Overview

    15.2. Western Europe Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cardiac Biomarkers Testing Market  

    16.1. UK Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cardiac Biomarkers Testing Market  

    17.1. Germany Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cardiac Biomarkers Testing Market  

    18.5. France Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cardiac Biomarkers Testing Market  

    19.9. Italy Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cardiac Biomarkers Testing Market  

    20.13. Spain Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cardiac Biomarkers Testing Market  

    21.1. Eastern Europe Cardiac Biomarkers Testing Market Overview

    21.2. Eastern Europe Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cardiac Biomarkers Testing Market  

    22.1. Russia Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cardiac Biomarkers Testing Market  

    23.1. North America Cardiac Biomarkers Testing Market Overview

    23.2. North America Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cardiac Biomarkers Testing Market  

    24.1. USA Cardiac Biomarkers Testing Market Overview

    24.2. USA Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cardiac Biomarkers Testing Market  

    25.1. Canada Cardiac Biomarkers Testing Market Overview

    25.2. Canada Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cardiac Biomarkers Testing Market  

    26.1. South America Cardiac Biomarkers Testing Market Overview

    26.2. South America Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cardiac Biomarkers Testing Market  

    27.1. Brazil Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cardiac Biomarkers Testing Market  

    28.1. Middle East Cardiac Biomarkers Testing Market Overview

    28.2. Middle East Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cardiac Biomarkers Testing Market  

    29.1. Africa Cardiac Biomarkers Testing Market Overview

    29.2. Africa Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cardiac Biomarkers Testing Market Competitive Landscape And Company Profiles

    30.1. Cardiac Biomarkers Testing Market Competitive Landscape

    30.2. Cardiac Biomarkers Testing Market Company Profiles

    30.2.1. Abbott Laboratories

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Bio-Rad Laboratories Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Danaher Corporation

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. F. Hoffmann-La Roche Ltd.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Siemens Healthineers AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Cardiac Biomarkers Testing Market Competitive Benchmarking

    32. Global Cardiac Biomarkers Testing Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Cardiac Biomarkers Testing Market

    34. Cardiac Biomarkers Testing Market Future Outlook and Potential Analysis

    34.1 Cardiac Biomarkers Testing Market In 2028 - Countries Offering Most New Opportunities

    34.2 Cardiac Biomarkers Testing Market In 2028 - Segments Offering Most New Opportunities

    34.3 Cardiac Biomarkers Testing Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cardiac Biomarkers Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cardiac Biomarkers Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Abbott Laboratories Financial Performance
  • Table 75: Bio-Rad Laboratories Inc. Financial Performance
  • Table 76: Danaher Corporation Financial Performance
  • Table 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 78: Siemens Healthineers AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cardiac Biomarkers Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cardiac Biomarkers Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Cardiac Biomarkers Testing Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cardiac Biomarkers Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cardiac Biomarkers Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Abbott Laboratories Financial Performance
  • Figure 75: Bio-Rad Laboratories Inc. Financial Performance
  • Figure 76: Danaher Corporation Financial Performance
  • Figure 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 78: Siemens Healthineers AG Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Cardiovascular Devices Global Market Report 2024 – By Type (Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiac Assist Devices And Equipment Global Market Report 2024 – By Type (Ventricular Assist Devices (LVAD), Intra-Aortic Balloon Pumps, Total Artificial Heart), By Modality (Transcutaneous, Implantable), By Application (Hospital Pharmacies, Ambulatory Surgical Centres, Emergency Services ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024 – By Product (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)), By Application (Bradycardia, Tachycardia, Heart Failure, Other Applications), By End User (Hospitals, Ambulatory surgical centers, Physicians Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiac Pacemakers Global Market Report 2024 – By Type (Implantable, External), By Technology (Biventricular, Single Chambered, Dual Chambered), By Application (Arrhythmias, Heart Blockage, Atrial Fibrillation, Long QT Syndrome, Congestive Cardiac Failure, Other Applications), By End User (Clinics And Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024 – By Product Type (Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems, Holter Monitoring Systems), By Type (Heart Disease, Coronary Heart Disease), By End-Use (Hospitals/Physician Clinic (Continuous Glucose Monitors), Home/Emergency, Research and Development (Clinical Trials, Universities, CRO)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Interventional Cardiology Devices And Equipment Global Market Report 2024 – By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Other Interventional Cardiology Devices), By Age Group (New-born (0-30 days), Infant (31 days-1 year), Children (1-18 years), Adult (18+ years)), By Application (Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiovascular Medical Lasers Global Market Report 2024 – By Type (Excimer Laser, Carbon Dioxide Laser), By Application (Laser Vascular Anastomosis, Transmyocardial Laser Revascularization, Laser Angioplasty For Peripheral Arterial Diseases), By End Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report

Frequently Asked Questions

What is the definition of the cardiac biomarkers testing market?

Cardiac biomarkers testing refers to the tests to evaluate the quantities of cardiac biomarkers in blood. It is used to diagnose, assess, and keep track of people who may have acute coronary syndrome (ACS). For further insights on the cardiac biomarkers testing market, request a sample here

How will the cardiac biomarkers testing market drivers and restraints affect the cardiac biomarkers testing market dynamics? What forces will shape the cardiac biomarkers testing industry going forward?

The cardiac biomarkers testing market major growth driver - rising prevalence of cardiovascular diseases fuels growth in the cardiac biomarkers testing market. For further insights on the cardiac biomarkers testing market, request a sample here

What is the forecast market size or the forecast market value of the cardiac biomarkers testing market ?

The cardiac biomarkers testing market size has grown rapidly in recent years. It will grow from $12.15 billion in 2023 to $13.63 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, aging population, awareness and education initiatives, government initiatives and healthcare policies, increasing healthcare expenditure. The cardiac biomarkers testing market size is expected to see rapid growth in the next few years. It will grow to $21.31 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to personalized medicine, rising global burden of cardiovascular diseases, integration of artificial intelligence (ai) in diagnostics, expansion of point-of-care testing, increasing emphasis on early disease detection. Major trends in the forecast period include technological advancements, advancements in ai-assisted diagnostics, point-of-care testing (poct) growth, multiplexing capabilities, biomarker discovery and validation. For further insights on the cardiac biomarkers testing market, request a sample here

How is the cardiac biomarkers testing market segmented?

The cardiac biomarkers testing market is segmented
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty ClinicsFor further insights on the cardiac biomarkers testing market, request a sample here

Which region has the largest share of the cardiac biomarkers testing market? What are the other regions covered in the report?

North America was the largest region in the cardiac biomarkers testing market in 2023. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the cardiac biomarkers testing market, request a sample here.

Who are the major players in the cardiac biomarkers testing market?

Major companies operating in the cardiac biomarkers testing market report are Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation . For further insights on the cardiac biomarkers testing market, request a sample here.

What are the key trends in the cardiac biomarkers testing market?

Major trend in the cardiac biomarkers testing market - breakthrough in cardiac biomarker testing with atellica vtli patient-side immunoassay analyzer. For further insights on the cardiac biomarkers testing market, request a sample here.

What are the major opportunities in the cardiac biomarkers testing market? What are the strategies for the cardiac biomarkers testing market?

For detailed insights on the major opportunities and strategies in the cardiac biomarkers testing market, request a sample here.

How does the cardiac biomarkers testing market relate to the overall economy and other similar markets?

For detailed insights on cardiac biomarkers testing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cardiac biomarkers testing industry?

For detailed insights on the mergers and acquisitions in the cardiac biomarkers testing industry, request a sample here.

What are the key dynamics influencing the cardiac biomarkers testing market growth? SWOT analysis of the cardiac biomarkers testing market.

For detailed insights on the key dynamics influencing the cardiac biomarkers testing market growth and SWOT analysis of the cardiac biomarkers testing industry, request a sample here.